On the HCPLive tardive dyskinesia page, resources on the topics of medical news and expert insight into TD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dyskinesias, and more.
February 6th 2019
The patient started treatment with resperidone at age 7 but wasn't diagnosed with tardive dyskinesia until age 17.
January 16th 2019
January 7th 2019
There were no significant differences among tardive syndrome patients and healthy controls in either resting motor function or active motor function, and both group's symptoms improved with raised intensity.
Recent studies questioned the benefits of second-generation antipsychotics, prompting researchers to reassess the risks of tardive dyskinesia from the use of first- and second-generation antipsychotics.
The FDA’s post-marketing review concludes a five-month speculation which began when CNN reported the Acadia Pharmaceutical antipsychotic therapy was associated with more than 700 deaths of patients with Parkinson disease since June 2016.
Data presented at the2018 World Congress on Parkinson's Disease and Related Disorders indicate that valbenazine is a promising treatment for tardive dyskinesia, while opicapone may be a new effective treatment for Parkinson disease.
Three-quarters of patients who discontinue antipsychotic treatment experience relapse within 12-18 months. However, there are no current clinical guidelines describing treatment continuation or discontinuation beyond 1-2 years.